Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria
Keywords:
Drug toxicity, Child, Hospitalization, Body burden, NigeriaAbstract
CONTEXT AND OBJECTIVES: Adverse drug reactions (ADRs) may cause prolonged hospital admissions with high treatment costs. The burden of ADRs in children has never been evaluated in Nigeria. The incidence of pediatric ADRs and the estimated cost of treatment over an 18-month period were determined in this study. DESIGN AND SETTING: Prospective observational study on children admitted to the pediatric wards of the Lagos State University Teaching Hospital (LASUTH) in Nigeria, between July 2006 and December 2007. METHODS: Each patient was assessed for ADRs throughout admission. Medical and non-medical costs to the hospital and patient were estimated for each ADR by reviewing the medical and pharmacy bills, medical charts and diagnostic request forms and by interviewing the parents. Cost estimates were performed in 2007 naira (Nigeria currency) from the perspectives of the hospital (government), service users (patients) and society (bearers of the total costs attributable to treating ADRs). The total estimated cost was expressed in 2007 United States dollars (USD). RESULTS: Two thousand and four children were admitted during the study; 12 (0.6%) were admitted because of ADRs and 23 (1.2%) developed ADR(s) during admission. Forty ADRs were suspected in these 35 patients and involved 53 medicines. Antibiotics (50%) were the most suspected medicines. Approximately 1.83 million naira (USD 15,466.60) was expended to manage all the patients admitted due to ADRs. CONCLUSIONS: Treating pediatric ADRs was very expensive. Pediatric drug use policies in Nigeria need to be reviewed so as to discourage selfmedication, polypharmacy prescription and sales of prescription medicines without prescription.
Downloads
References
Pirmohamed M, Park BK. Adverse drug reactions: back to the future. Br J Clin Pharmacol. 2003;55(5):486-92.
Oshikoya KA, Njokanma OF, Chukwura HA, Ojo IO. Adverse drug reactions in Nigerian Chil- dren. Paediatric and Perinatal Drug Therapy. 2007;8(2):81-8. Available from: http://www.ingentaconnect.com/content/apl/ppdt/2007/00000008/00000002/art00007. Acces- sed in 2011 (Jan 27).
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-5.
Mbuagbaw J, Mbuagbaw LCE, Chiabi A, Bisseck C, Nkam M. Mucocutaneous adverse drug reactions in a hospital setting in Cameroon. The Internet Journal of Dermatology. 2008;6(2). Available from: http://www.ispub.com/journal/the_internet_journal_of_dermatology/volume_6_number_2_2/article/mucocutaneous_adverse_drug_reactions_in_a_hospi-tal_setting_in_cameroon.html. Accessed in 2011 (Jan 27).
Mehta U, Durrheim DN, Blockman M, et al. Adverse drug reactions in adult medical inpa- tients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008;65(3):396-406.
Weiss J, Krebs S, Hoffmann C, et al. Survey of adverse drug reactions on pediatric ward: a strategy for early and detailed detection. Paediatrics. 2002;110(2 Pt 1):254-7.
Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in paedia- tric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52(1):77-83.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747-57.
Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients: a systema- tic review of the prospective and retrospective studies. Bandolier Extra. 2002:1-15. Avai- lable from: http://www.medicine.ox.ac.uk/bandolier/Extraforbando/ADRPM.pdf. Accessed in 2011 (Jan 27).
Ayani I, Aguirre C, Gutiérrez G, et al. A cost-analysis of suspected adverse drug reactions in a hospital emergency ward. Pharmacoepidemiol Drug Saf. 1999;8(7):529-34.
Wu WK, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitaliza- tion. Am J Health Syst Pharm. 2003;60(3):253-9.
Patel KJ, Kedia MS, Bajpai D, et al. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007;7:8.
Jonville-Béra AP, Giraudeau B, Blanc P, Beau-Salinas F, Autret-Leca E. Frequency of adverse drug reactions in children: a prospective study. Br J Clin Pharmacol. 2002;53(2):207-10.
Clarkson A, Ingleby E, Choonara I, Bryan P, Arlett P. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child. 2001;84(4):337-9.
Oshikoya KA, Njokanma OF, Bello JA, Ayorinde EO. Family self-medication for children in an urban area of Nigeria. Paediatric and Perinatal Drug Therapy. 2007;8(3):124-30. Available from: http://www.ingentaconnect.com/content/apl/ppdt/2007/00000008/00000003/art00008. Accessed in 2011 (Jan 27).
Oshikoya KA, Chukwura HA, Ojo IO. Evaluation of outpatient paediatric drug prescriptions in a teaching hospital in Nigeria for rational prescribing. Paediatric and Perinatal Drug Therapy 2006;7(4):183-8. Available from http://www.ingentaconnect.com/content/apl/ppdt/2006/00000007/00000004/art00006. Accessed in 2011 (Jan 27).
Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J. Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol. 2001;56(12):935-41.
Porter J, Jick H. Drug-related deaths among medical inpatients. JAMA. 1977;237(9): 879-81.
Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155(18):1949-56.
Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255-9.
Pirmohammed M, James S, Meakin S, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329(7456):15-9.
Association of the British Pharmaceutical Industry. ABPI data sheet compendium. London: Datapharm Communications Ltd.; 2005.
EMDEX. The complete drug formulary for Nigeria’s health professionals: with guide to drug administration. Canada: Lindoz books; 2006.
British Medical Association, Royal Pharmaceutical Society of Great Britain, Royal College of Paediatrics and Child Health, Neonatal and Paediatric Pharmacists Group. British National Formulary for Children. London: BMJ, RPS, RCPCH; 2006.
Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In: Davies DM, editors. Textbook of ADRs. Oxford: Oxford University Press; 1997. p. 10.
Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12(3):194-200.
World Health Organization Collaborating Centre for International Drug Monitoring of Adverse Reaction Terminology. Switzerland: the Uppsala Monitoring Centre; 2002.
Jones JK. Adverse drug reactions in the community health setting: approaches to recogni- zing, counseling, and reporting. Fam Community Health. 1982;5(2):58-67.
Schirm E, Tobi H, van Puijenbroek EP, Monster-Simons MH, de Jong-van den Berg LT. Repor- ted adverse drug reactions and their determinants in Dutch children outside the hospital. Pharmacoepidemiol Drug Saf. 2004;13(3):159-65.
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27(6):538.
Oshikoya KA, Senbanjo IO, Njokanma OF. Parental reporting of suspected adverse drug reac- tions in children in Lagos, Nigeria. Arch Dis Child. 2009;94(6):469-73.
Kiriti TW, Tisdell C. Family size, economics and child gender preference: a case study in the Nyeri district Kenya. International Journal of Social Economics. 2005;32(6):492-509. Available from: http://www.deepdyve.com/lp/emerald-publishing/family-size-economics-and-child-gender-preference-a-case-study-in-the-04jfrbw03n. Accessed in 2011 (Jan 27).
Feyisetan BJ, Asa S, Ebigbola JA. Mothers’ management of childhood diseases in Yoruba- land: the influence of cultural beliefs. Health Transit Rev. 1997;7(2):221-34.
Okezie EO, Olufunmilayo F. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf. 2008;17(5):517-22.
Jarernsiripornkul N, Krska J, Capps PAG, Richards RME, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol. 2002;53(3):318-25.
Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res. 2006;54(3):226-33.
Agbabiaka TB, Savović J, Ernst E. Methods for causality assessment of adverse drug reac- tions: a systematic review. Drug Saf. 2008;31(1):21-37.
Ducharme MM, Boothby LA. Analysis of adverse drug reactions for preventability. Int J Clin Pract. 2007;61(1):157-61.
Evans RS, Pestotnik SL, Classen DC, et al. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28(4):523-7.
Dormann H, Criegee-Rieck M, Neubert A, et al. Implementation of a computer-assisted mo- nitoring system for the detection of adverse drug reactions in gastroenterology. Aliment Pharmacol Ther. 2004;19(3):303-9.
Pirmohamed M, Ferner RE. Monitoring drug treatment. BMJ. 2003;327(7425):1179-81.
Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpa- tients: a prospective study. Lancet. 2002;359(9315):1373-8.
Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital-- their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12(8):687-92.
Chan ALF, Lee HY, Ho CH, Cham TM, Lin SJ. Cost evaluation of adverse drug reactions in hospitalized patient in Taiwan: A prospective, descriptive, observational study. Current Thera- peutic Research. 2008;69(2):118-29. Available from: http://www.journals.elsevierhealth.com/periodicals/cuthre/article/PIIS0011393X08000398/abstract. Accessed in 2011 (Jan 27).
Oyedeji GA. Socio-economic and cultural background of hospitalized children in Ilesa. Nig J Paediatr. 1985;12(4):111-7.
United Nations Development Group. Indicators for Monitoring the Millennium Development Goals. New York: United Nations Publication. Available from: http://unstats.un.org/unsd/mdg/Resources/Attach/Indicators/HandbookEnglish.pdf. Accessed in 2011 (May 25).
Fetuga B, Ogunlesi T, Adekanmbi F, Olanrewaju D, Olowu A. Comparative analyses of chil- dhood deaths in Sagamu, Nigeria: implications for the fourth MDG. SA Journal of Child Health. 2007;1(3):106-11. Available from: http://www.sajch.org.za/index.php/SAJCH/article/viewFile/16/25. Accessed in 2011 (Jan 27).
Aiyeko P, Akumu AO, Griffiths UK, English M. The economic burden of inpatient paediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis. Cost Eff Resour Alloc. 2009,7:3.
